Range of heart rate observations during the pre-therapy period and placebo and exenatide treatment. The range of observed heart rates at pre-therapy (A) and on placebo (B) treatment overlapped with the range observed on exenatide (C). , pre-therapy (Day −1); , placebo; , 200 pg ml−1 target exenatide concentration (Day 1); , 300 pg ml−1 target exenatide concentration (Day 2); , 500 pg ml−1 target exenatide concentration (Day 3)